Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19

NCT04395144 is registered in ClinicalTrials.gov with Hôpital de Verdun as lead sponsor.

NCT NCT04395144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04395144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized-controlled Trial of HFNC Alone vs HFNC and Awake Self-proning for Treatment of Severe COVID-19
Lead sponsor
Hôpital de Verdun
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2020
Completion date
March 15, 2021
Enrollment
13 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ards, coronavirus infection, covid, lung diseases, respiratory distress syndrome, respiratory failure, respiratory insufficiency, severe acute respiratory syndrome